Glutathione is a tripeptide composed of cysteine, glutamine, and glycine. It is produced endogenously and functions as the body’s primary defence against oxidative stress. Every cell contains glutathione, and its depletion is one of the most consistent markers of cellular ageing and chronic disease.

Glutathione and the Antioxidant System

Glutathione is a tripeptide composed of cysteine, glutamine, and glycine. It is produced endogenously and functions as the body’s primary defence against oxidative stress. Every cell contains glutathione, and its depletion is one of the most consistent markers of cellular ageing and chronic disease. When glutathione is depleted, oxidative damage accumulates — lipids oxidise, proteins become dysfunctional, and DNA damage accumulates in the cell.

Cysteine is the rate-limiting amino acid in glutathione synthesis. The body needs cysteine to make glutathione, and NAC provides a bioavailable form of cysteine that can be used for this purpose. Directly supplementing glutathione is less effective than supplementing NAC because glutathione taken orally is broken down in the gut before absorption. NAC, as a small molecule, is absorbed more reliably and then used by cells to synthesise glutathione on demand.

The Liver Protection Effect

NAC has been used in hospital settings as an antidote to acetaminophen overdose for decades. It works by replenishing glutathione stores, which are depleted when the liver metabolises large amounts of acetaminophen. This same mechanism — supporting glutathione-dependent detoxification pathways — is relevant at lower, ongoing doses for people concerned about liver health from alcohol consumption, medication use, or environmental toxin exposure.

The research on NAC and non-alcoholic fatty liver disease is promising. Several clinical trials have shown that NAC supplementation improves liver enzyme markers and reduces oxidative stress in people with NAFLD, likely through the same glutathione repletion mechanism. The dose used in these studies is typically 600 to 1800 milligrams daily, divided into two or three doses.

Neuroprotection and Brain Health

The brain is particularly vulnerable to oxidative stress because it consumes large amounts of oxygen and has a relatively high concentration of polyunsaturated fatty acids that are susceptible to lipid peroxidation. Glutathione plays a critical role in protecting neurons from oxidative damage, and glutathione depletion is a consistent finding in neurodegenerative diseases including Parkinson’s and Alzheimer’s.

NAC has been studied in psychiatric applications as well. It has glutamate-modulating properties — NAC regulates the glutamate neurotransmitter system by increasing glutamate reuptake and reducing extracellular glutamate accumulation. This is clinically relevant for obsessive-compulsive disorder, where elevated glutamate signalling drives compulsive behaviours. Several RCTs have shown NAC as an effective adjunctive treatment for OCD at doses of 2400 to 3000 milligrams daily.

Respiratory Applications

NAC’s mucolytic properties — it breaks disulfide bonds in mucus — have been exploited clinically for decades in respiratory medicine. It is used in hospital settings via nebuliser for cystic fibrosis, COPD, and bronchiectasis to reduce mucus viscosity and improve clearance. At lower doses in oral supplement form, it is proposed to support respiratory health through the same mechanism, though the evidence is less robust than for the clinical applications.

Dosing and Practical Considerations

The standard dose range for NAC supplementation is 600 to 1800 milligrams daily, typically divided into two or three doses. Taking it with food is fine — NAC is absorbed throughout the gastrointestinal tract. Some people prefer taking it on an empty stomach for faster absorption, but the difference is marginal.

NAC supplements should be stored away from moisture and heat, as the compound is somewhat hygroscopic and can degrade under humid conditions. Capsules are generally more stable than tablets for this reason.

One consideration: NAC can increase copper excretion, so long-term high-dose supplementation should be accompanied by a copper or multi-mineral supplement to avoid deficiency.

Combining NAC With Other Compounds

NAC stacks effectively with selenium, which is a cofactor for glutathione peroxidase — the enzyme that uses glutathione to neutralise peroxides. The combination means glutathione is both synthesised more efficiently and deployed more effectively. NAC also combines well with milk thistle — silymarin from milk thistle has independent hepatoprotective effects through a different mechanism, providing complementary liver support. Alpha lipoic acid is another synergist, as it also supports glutathione regeneration and has independent antioxidant properties.

Who Should Consider NAC

NAC is worth considering for several distinct populations. People taking medications that are hard on the liver — including acetaminophen, some antibiotics, and certain anticonvulsants — may benefit from NAC’s hepatoprotective effects at doses of 600 to 1200 milligrams daily. People with chronic fatigue syndrome or fibromyalgia-like symptoms have shown modest improvements in fatigue scores in small trials, possibly through glutathione-supported mitochondrial function. Those with significant alcohol consumption — more than 2 drinks daily — can use NAC as part of a liver support protocol, alongside milk thistle and selenium.

For cognitive health purposes, NAC is most relevant for people over 50 with family histories of neurodegenerative disease, or anyone concerned about age-related cognitive decline. The neuroprotective mechanism is distinct from the cognitive effects of other nootropics, making it a complementary addition to a cognitive health stack rather than a standalone cognitive enhancer.

NAC and Respiratory Infections

During the COVID-19 pandemic, NAC received attention for its potential role in respiratory outcomes. Several retrospective analyses found that NAC supplementation was associated with reduced severity of respiratory symptoms in hospital settings, likely through its mucolytic effects and reduction of oxidative stress in the airways. The mechanism is not antiviral but supportive — NAC helps maintain the clearance function of the respiratory mucosa and reduces the oxidative damage that accompanies severe respiratory infection.

This does not mean NAC prevents respiratory infections, but it may reduce their severity. For people with chronic respiratory conditions — COPD, bronchiectasis, cystic fibrosis — NAC supplementation at 600 to 1800 milligrams daily is a reasonable part of a management protocol. The evidence is stronger in these clinical populations than in healthy adults using NAC for general health purposes.